PATENT CLAIM ANALYSIS

Application Number: 15768648
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-02
Patent Classification: ["514", "252110"]

Abstract:
Anti-angiogenic treatments, for example treatment of ocular neovascularization or cancer, treatments of hyperpermeability disorders, treatments of neuropathic and neurodegenerative disorders, pain treatments, methods of treating or preventing fibrosis and compounds for use in such methods are described.

Claim (Index 27):
A compound according to  claim 26 , wherein R 4  is a methyl group substituted with phenyl or a 5- or 6-membered aromatic heterocycle.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 91.0
- Lexical Diversity: 1.53571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15304678', '15708315', '14488601', '13059659', '10590026']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7686754973498193
- 35 USC 102 Novelty (BERT): 0.5383699961838854
- Combined Prediction Score: 0.7456449472332259
- Mean Citation Score: 329.7354660000001
- Max Citation Score: 353.65442
- Similarity Product: 244.91023732399705

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test